IBIS has built up an enviable reputation as a source of high-level information and market analysis; a forum for high-level debate; a melting pot of innovative approaches to industry problems and, of course, incomparable networking opportunities. World-class conference content and speakers are the driving force behind the success of IBIS conferences. IBIS consistently delivers groundbreaking thought-leading presentations on a wide range of issues that consistently receive outstanding feedback from delegates. Whether it is a local Forum event, a larger Regional or the Global Summit itself, IBIS looks at the present and future opportunities and challenges to give all delegates a competitive edge. Mitchell will once again be attending IBIS as an exhibitor, in addition to having a speaking engagement. We look forward to seeing you at IBIS! Need to schedule a meeting with a sales representative? Contact us today.
More stories
South Carolina Approves Fee Schedule Changes
April 5, 2022
The South Carolina Workers’ Compensation Commission approved changes to the Medical Services Provider Manual, effective April 1, 2022.
Mitchell Introduces New Commercial Truck Estimating Solution
April 5, 2022
Insurers and repairers can now use Mitchell’s cloud-based technology for appraisals of collision-damaged passenger and specialty vehicles, mot
Business Insurance: “Drug Formularies Not a Top Legislative Priority this Year”
April 4, 2022
High Dollar Claims Driving Workers’ Compensation COVID-19 Claims Costs
March 29, 2022
Data analysis by Aarthi Thiruvengadam.
Symbicort Generic Approval on March 15, 2022
March 29, 2022
Recently the U.S. Food and Drug Administration (FDA) approved a generic formulation of Symbicort metered-dose inhaler for the treatment of asthma or chronic obstructive pulmonary disease (COPD).
The Rise of Fentanyl in the Midst of an Already Troubling Opioid Epidemic
March 24, 2022
Each day we hear more and more stories of addiction, overdose, and deaths with heartbreaking stories of the individuals and the families who have been impacted by the opioid epidemic. In an attempt to address this crisis, more aggressive clinical intervention and opioid management programs are being adopted, and opioid use has steadily decreased for workers’ compensation patients; however, according to an NSC survey, 75% of employers are being directly impacted by employee opioid misuse.